This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Antoine Depaulis: Innovator in Epilepsy Treatment
Introduction
Antoine Depaulis is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of medical science, particularly in the treatment of epilepsy. His innovative approach has garnered attention and recognition in the scientific community.
Latest Patents
Antoine Depaulis holds a patent for a method of treating epilepsy. This method involves the therapeutic use of brain-derived neurotrophic factor (BDNF) to effectively treat the condition. His work in this area represents a promising advancement in epilepsy treatment.
Career Highlights
Antoine is currently associated with Amgen Inc., a leading biotechnology company. His role at Amgen allows him to further his research and development efforts in the medical field. His dedication to improving patient outcomes is evident in his work.
Collaborations
Antoine has collaborated with several esteemed colleagues, including Josette Francedillaoise Carnahan and Paul Feltz. These partnerships have contributed to the advancement of his research and the development of innovative solutions in healthcare.
Conclusion
Antoine Depaulis is a pioneering inventor whose work in epilepsy treatment showcases the potential of innovative medical therapies. His contributions to the field are invaluable and highlight the importance of continued research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile